Jeffrey Alan Jones
Chief Medical Officer · Cullinan Therapeutics, Inc.
- 2024
- Feb 25, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey Alan Jones files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $3.50M in CGEM purchases and sales in the last 12 months
- Jennifer Michaelson - $1.62M in CGEM purchases and sales in the last 12 months
- Nadim Ahmed - $518K in CGEM purchases and sales in the last 12 months
- Jacquelyn L. Sumer - $137K in CGEM purchases and sales in the last 12 months
- Mary Kay Fenton - $60K in CGEM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Alan Jones?
Jeffrey Alan Jones is a corporate insider, tracked as Chief Medical Officer of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jeffrey Alan Jones last file a Form 4?
The most recent primary Form 4 on record is dated 25 February 2026, one of 5 filings going back to 2024.
Has Jeffrey Alan Jones been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($232K) across all tracked filings.
